Medication info
Dapagliflozin SM Prolonged-release Tablet 10/100/1000 mg (Dapagliflozin, Sitagliptin, Metformin)

Dapagliflozin SM Prolonged-release Tablet 10/100/1000 mg (Dapagliflozin, Sitagliptin, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletDapagliflozin Propanediol Hydrate›12.3mg / 1 tabletSitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Yellow to deep yellow, oval-shaped prolonged-release film-coated tablets with both sides convex
Packaging
Bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 202403108 · Approved 2024.12.31 · Insurance code 648105170

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended doses of this medicine for antidiabetic therapy are dapagliflozin 10 mg and sitagliptin 100 mg. The dose of extended-release metformin hydrochloride, not exceeding 2000 mg, should be determined considering each patient's current treatment regimen, efficacy, and tolerability. To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, this medicine should be taken once daily in the evening with a meal. Patients taking this medicine as a 10/100/1000 mg extended-release tablet should take one tablet once daily; for the 5/50/1000 mg extended-release tablet, take two tablets together once daily. To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist in blood sugar control in patients with type 2 diabetes when used in conjunction with dapagliflozin, sitagliptin, and metformin. When taken alongside dietary and exercise therapy, it can effectively improve blood sugar levels. This helps manage diabetes and contributes to maintaining a healthy lifestyle.

How to take

Adult dose

The recommended doses of this medicine for antidiabetic therapy are dapagliflozin 10 mg and sitagliptin 100 mg. The dose of extended-release metformin hydrochloride, not exceeding 2000 mg, should be determined considering each patient's current treatment regimen, efficacy, and tolerability. To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, this medicine should be taken once daily in the evening with a meal. Patients taking this medicine as a 10/100/1000 mg extended-release tablet should take one tablet once daily; for the 5/50/1000 mg extended-release tablet, take two tablets together once daily. To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew.

Precautions

This medication is a diabetes treatment that combines three components: sitagliptin, dapagliflozin, and metformin. Firstly, the sitagliptin component can rarely cause serious allergic reactions. If you notice symptoms such as skin rash, difficulty breathing, or facial swelling after taking it, you should immediately stop taking the medication and consult a physician. Additionally, acute pancreatitis, a condition involving inflammation of the pancreas, may occur, so if you experience severe abdominal pain, vomiting, or fever, you should visit a hospital right away. Next, metformin can rarely cause severe metabolic disorder known as lactic acidosis. If sudden difficulty in breathing, muscle pain, weakness, or abdominal pain occurs, you must inform your healthcare provider immediately. This medication should not be used in patients with moderate or severe renal impairment or in cases of dehydration, severe infection, acute myocardial infarction, sepsis, or acute heart failure. Particularly before and after any imaging procedures using contrast agents, it is advisable to temporarily discontinue use due to the risk of worsening renal function and lactic acidosis, as well as to pause the medication before and after surgical procedures for safety. During treatment, symptoms such as low blood pressure and decreased fluid volume may occur, so watch for dizziness and signs of dehydration. Elderly patients or those with compromised renal function should be monitored more closely. Moreover, this medication may increase the risk of genital and urinary tract infections, and proper treatment should be sought if any signs of infection arise. When used in conjunction with other medications for blood sugar control, the risk of hypoglycemia may increase. Immediate action should be taken if symptoms of hypoglycemia such as cold sweat, trembling, headache, or confusion arise. Routine evaluations of liver and kidney function should be conducted while taking this medication, and if any signs of abnormality appear, you must inform healthcare personnel immediately. If you experience fever, pain in the genital or perineal area, redness, or swelling during treatment, it could indicate serious perineal necrosis disease, and immediate treatment should be sought. Finally, it is advisable to avoid alcohol consumption during treatment with this medication. If fluid volume decreases, dehydration, or acute illness occur, temporarily discontinuing the medication and consulting a physician is recommended.

Side effects

  • Severe allergic reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hemorrhagic pancreatitis
  • necrotizing pancreatitis
  • lactic acidosis
  • hypoglycemia
  • genital infections
Show 112 more
  • vulvitis
  • balanitis
  • fungal infections
  • perineal necrosis
  • decreased fluid volume
  • dry mouth
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • elevated hematocrit
  • increased serum creatinine
  • elevated blood urea
  • dyslipidemia
  • urinary tract infections
  • decreased renal creatinine clearance
  • renal impairment
  • elevated blood creatinine
  • worsening renal function
  • rash
  • generalized rash
  • pruritic rash
  • maculopapular rash
  • pustular rash
  • vesicular rash
  • erythematous rash
  • gastroesophageal reflux disease
  • upper abdominal pain
  • diverticulosis
  • intestinal perforation
  • chronic pancreatitis
  • hyperglycemia
  • paresthesia
  • cerebral infarction
  • nerve compression
  • sinusitis
  • diverticulitis
  • pelvic inflammatory disease
  • pneumonia
  • pulmonary tuberculosis
  • weakness
  • pain
  • ligament sprain
  • traffic accident
  • drug overdose
  • ankle fracture
  • hand fracture
  • pelvic fracture
  • meniscal injury
  • thoracic vertebra fracture
  • tibial fracture
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • bile duct stones
  • cholangitis
  • alcoholic cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • acute pyelonephritis
  • chest pain
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • urinary retention
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • decreased appetite
  • subsequent phenomenon
  • headache
  • nasopharyngitis
  • chest discomfort
  • peripheral edema
  • generalized edema
  • hunger
  • vaginal discharge
  • menstrual irregularity
  • pruritus
  • urticaria
  • cold sweat
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic retinopathy
  • cough
  • dyspnea
  • orthostatic hypotension
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyps
  • tinnitus
  • taste impairment
  • erythema
  • urticaria
  • rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain room temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow to deep yellow, oval-shaped prolonged-release film-coated tablets with both sides convex

Package unit

Bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.